OlgpØyHKtCvØCedtCptrlcdc rlUdte.Ørlin rØ,dsØo
| Firstauthor [ref.no.] | Radiatio | Schedule week | Concurrent | Arm | Patientsn | Chemotherapy, regime |
| Work 21 | 45 Gy/22F | 1–2 & 6–7 | No | Early | 99 | P: 60 mgm−2 day 1 |
| Splitcourse | 18–19 & 23–24 | No | Late | 100 | E: 120 mgm−2 day 1–3 | |
| Gregor 22 | 50 Gy/20F | 6, 10, 14, 18 | No | Alt. | 169 | CTX: 1 g·m−2 day 1 |
| ADR: 45 mgm−2 day 1 | ||||||
| 14–17 | NO | Seq | 165 | E: 100 mgm−2 day 1–3 | ||
| Johnson 23 | 30 Gy/10F | 1–2 | Yes | Early | 156 | CTX: 1 g·m−2 day 1 |
| ADR: 40 mgm−2 day 1 | ||||||
| Noirr. | 230 | VCR 1 mgm−2 day 1 | ||||
| Murray 20 | 40 Gy/15F | 3–5 | Yes | Early | 155 | P: 25 mgm−2 day 1–3+ |
| 15–17 | Yes | Late | 153 | E: 100 mgm−2 day 1–3 |
Alt.: alternating
Seq: sequential
P: cispain
E: etoposide
CTX: cyclophosphamide
VCR vinoristine
ADR: doxorubicire
F: Fraction
irr.: Irradiation